XML 28 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

Earnings Per Share Data ("EPS") and Stock Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Earnings Per Share Data ("EPS") and Stock Based Compensation | (8) Earnings Per Share Data (“EPS”) and Stock Based Compensation Basic earnings per share are based on the weighted average number of common shares outstanding during the period. Diluted earnings per share are based on the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents. The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):
|  | Three months ended June 30, |  |  | Six months ended June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Basic and Diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income attributable to UHS |  | $ | 251,929 |  |  | $ | 238,320 |  |  | $ | 393,966 |  |  | $ | 472,488 |
Less: Net income attributable to unvested restricted share grants |  |  | (824 | ) |  |  | (656 | ) |  |  | (1,197 | ) |  |  | (1,171 | )
Net income attributable to UHS – basic and diluted |  | $ | 251,105 |  |  | $ | 237,664 |  |  | $ | 392,769 |  |  | $ | 471,317 |
Weighted average number of common shares - basic |  |  | 84,632 |  |  |  | 89,136 |  |  |  | 85,422 |  |  |  | 89,956 |
Net effect of dilutive stock options and grants based on the treasury stock method |  |  | 427 |  |  |  | 99 |  |  |  | 335 |  |  |  | 145 |
Weighted average number of common shares and equivalents - diluted |  |  | 85,059 |  |  |  | 89,235 |  |  |  | 85,757 |  |  |  | 90,101 |
Earnings per basic share attributable to UHS: |  | $ | 2.97 |  |  | $ | 2.67 |  |  | $ | 4.60 |  |  | $ | 5.24 |
Earnings per diluted share attributable to UHS: |  | $ | 2.95 |  |  | $ | 2.66 |  |  | $ | 4.58 |  |  | $ | 5.23 |
The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all periods presented above, excludes certain outstanding stock options applicable to each period since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 7.1 million for the three months ended June 30, 2020 and 6.5 million for the six months ended June 30, 2020. The excluded weighted-average stock options totaled 8.5 million for the three months ended June 30, 2019 and 7.8 million for the six months ended June 30, 2019. All classes of our common stock have the same dividend rights. The decrease in our basic and diluted weighted number of common shares outstanding for the three and six months ended June 30, 2020, as compared to the comparable prior year three and six months, was due primarily to the impact of shares repurchased by us since January 1, 2019. Stock-Based Compensation: During the three-month periods ended June 30, 2020 and 2019, pre-tax compensation cost of $13.2 million and $14.7 million, respectively, was recognized related to outstanding stock options. During the six-month periods ended June 30, 2020 and 2019, pre-tax compensation costs of $28.6 million and $30.5 million, respectively, was recognized related to outstanding stock options. In addition, during the three-month periods ended June 30, 2020 and 2019, pre-tax compensation cost of approximately $2.4 million and $2.1 million (net of cancellations), respectively, was recognized related to restricted stock. During the six-months periods ended June 30, 2020 and 2019, pre-tax compensation costs of approximately $4.7 million and $3.7 million (net of cancellations), respectively, was recognized related to restricted stock. As of June 30, 2020 there was approximately $128.1 million of unrecognized compensation cost related to unvested options and restricted stock which is expected to be recognized over the remaining weighted average vesting period of 2.6 years. There were 2,545,966 stock options granted during the first six months of 2020 with a weighted-average grant date fair value of $14.25 per share. There were 125,467 shares of restricted shares granted during the first six months of 2020 with a weighted-average grant date fair value of $68.06 per share. The expense associated with stock-based compensation arrangements is a non-cash charge. In the Condensed Consolidated Statements of Cash Flows, stock-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $34.0 million and $34.7 million during the six month periods ended June 30, 2020 and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration